Cargando…

MiR-146a Contributes to Thromboinflammation and Recurrence in Young Patients with Acute Myocardial Infarction

Studies on older patients have established notable conceptual changes in the etiopathogenesis of acute coronary syndrome (ACS), but little is known about this disease in young patients (<45 years). Of special interest is thromboinflammation, key at onset, evolution and therapy of cardiovascular p...

Descripción completa

Detalles Bibliográficos
Autores principales:	de los Reyes-García, Ascensión M., Rivera-Caravaca, José Miguel, Zapata-Martínez, Laura, Águila, Sonia, Véliz-Martínez, Andrea, García-Barberá, Nuria, Gil-Perez, Pablo, Guijarro-Carrillo, Pedro J., Orenes-Piñero, Esteban, López-García, Cecilia, Lozano, María L., Marín, Francisco, Martínez, Constantino, González-Conejero, Rocío
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318357/ https://www.ncbi.nlm.nih.gov/pubmed/35887682 http://dx.doi.org/10.3390/jpm12071185

Ejemplares similares

microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation
por: de los Reyes-García, Ascensión M., et al.
Publicado: (2023)

Inflammatory microRNAs in cardiovascular pathology: another brick in the wall
por: Zapata-Martínez, Laura, et al.
Publicado: (2023)

miR-146a is a pivotal regulator of neutrophil extracellular trap formation promoting thrombosis
por: Arroyo, Ana B., et al.
Publicado: (2020)

Pilot Study on the Role of Circulating miRNAs for the Improvement of the Predictive Ability of the 2MACE Score in Patients with Atrial Fibrillation
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2020)

miR-146a deficiency in hematopoietic cells is not involved in the development of atherosclerosis
por: del Monte, Alberto, et al.
Publicado: (2018)

MicroRNAs as New Regulators of Neutrophil Extracellular Trap Formation
por: Águila, Sonia, et al.
Publicado: (2021)

Conservatively managed patients with non-ST-segment elevation acute coronary syndrome are undertreated with indicated medicines
por: Candela, Elena, et al.
Publicado: (2018)

Neutrophil extracellular traps and von Willebrand factor are allies that negatively influence COVID‐19 outcomes
por: Fernández‐Pérez, María P., et al.
Publicado: (2021)

Therapeutic management and one-year outcomes in elderly patients with acute coronary syndrome
por: Orenes-Piñero, Esteban, et al.
Publicado: (2017)

MiRNA-Based Regulation of Hemostatic Factors through Hepatic Nuclear Factor-4 Alpha
por: Salloum-Asfar, Salam, et al.
Publicado: (2016)

Control of post-translational modifications in antithrombin during murine post-natal development by miR-200a
por: Teruel, Raúl, et al.
Publicado: (2013)

Gut Microbiota and the Quality of Oral Anticoagulation in Vitamin K Antagonists Users: A Review of Potential Implications
por: Camelo-Castillo, Anny, et al.
Publicado: (2021)

Role of CD39 in COVID-19 Severity: Dysregulation of Purinergic Signaling and Thromboinflammation
por: Díaz-García, Elena, et al.
Publicado: (2022)

Platelets as Mediators of Thromboinflammation in Chronic Myeloproliferative Neoplasms
por: Marin Oyarzún, Cecilia P., et al.
Publicado: (2019)

Disparities in the Estimation of Glomerular Filtration Rate According to Cockcroft‐Gault, Modification of Diet in Renal Disease‐4, and Chronic Kidney Disease Epidemiology Collaboration Equations and Relation With Outcomes in Patients With Acute Coronary Syndrome
por: Rivera‐Caravaca, José Miguel, et al.
Publicado: (2018)

Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Focused Review on Oral Anticoagulation
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2021)

Hydroxytyrosol: Its role in the prevention of cardiovascular diseases
por: Noguera-Navarro, Clara, et al.
Publicado: (2023)

P987: IRAK1 AND JAK2 DUAL INHIBITION WITH PACRITINIB PREVENTS MYELOFIBROSIS-LIKE PHENOTYPE IN AN INFLAMMATION-DRIVEN MURINE MODEL
por: Zamora, Ernesto José Cuenca, et al.
Publicado: (2023)

P990: NF-ΚB AND JAK/STAT PATHWAYS INHIBITION REVERSES FIBROSIS IN A MURINE MODEL OF INFLAMMATION-DRIVEN MYELOFIBROSIS
por: Zamora, Ernesto José Cuenca, et al.
Publicado: (2023)

High medium-term incidence of major cardiovascular events in discharged patients with unstable angina
por: Herrero-Brocal, Marta, et al.
Publicado: (2023)

Regulation of Coagulation Factor XI Expression by MicroRNAs in the Human Liver
por: Salloum-Asfar, Salam, et al.
Publicado: (2014)

Evidences of SARS-CoV-2 virus air transmission indoors using several untouched surfaces: A pilot study
por: Orenes-Piñero, Esteban, et al.
Publicado: (2021)

Platelets, Thromboinflammation and Neurovascular Disease
por: Sun, Ying, et al.
Publicado: (2022)

Thromboinflammation and the hypercoagulability of COVID‐19
por: Connors, Jean M., et al.
Publicado: (2020)

Platelet Versus Megakaryocyte: Who Is the Real Bandleader of Thromboinflammation in Sepsis?
por: Garcia, Cédric, et al.
Publicado: (2022)

Platelets and Immune Responses During Thromboinflammation
por: Mezger, Matthias, et al.
Publicado: (2019)

Thromboinflammation response to tocilizumab in COVID‐19
por: Gergi, Mansour, et al.
Publicado: (2020)

Platelets, Macrophages, and Thromboinflammation in Chagas Disease
por: Choudhuri, Subhadip, et al.
Publicado: (2022)

Chemokines, molecular drivers of thromboinflammation and immunothrombosis
por: Leberzammer, Julian, et al.
Publicado: (2023)

Inflammasome Signaling, Thromboinflammation, and Venous Thromboembolism
por: Potere, Nicola, et al.
Publicado: (2023)

The PI3Kδ Inhibitor Idelalisib Diminishes Platelet Function and Shows Antithrombotic Potential
por: Barrachina, María N., et al.
Publicado: (2021)

Confirmation of radiant catalytic ionization efficacy for airborne SARS-CoV-2 elimination indoors using “COVID19 traps”
por: Orenes-Piñero, Esteban, et al.
Publicado: (2022)

Confirmation of SARS-CoV-2 airborne dissemination indoors using “COVID-19 traps”
por: Orenes-Piñero, Esteban, et al.
Publicado: (2022)

Thromboinflammation in COVID-19 acute lung injury
por: Mitchell, William Beau
Publicado: (2020)

Editorial: Platelets and Immune Responses During Thromboinflammation
por: Schattner, Mirta, et al.
Publicado: (2020)

Complement inhibition in biomaterial- and biosurface-induced thromboinflammation
por: Ekdahl, Kristina N., et al.
Publicado: (2016)

Phosphatidylserine is an overlooked mediator of COVID-19 thromboinflammation
por: Lind, Stuart E.
Publicado: (2021)

COVID-19 and Thromboinflammation: Is There a Role for Statins?
por: Ferrari, Filipe, et al.
Publicado: (2021)

Thromboinflammation in coronavirus disease 2019: The clot thickens
por: Iffah, Raayma, et al.
Publicado: (2021)

The Role of CLEC-2 and Its Ligands in Thromboinflammation
por: Meng, Danyang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sg8h7sqns9bl269a7tlobnqfpq